China grants country's 1st Covid-19 vaccine patent to domestic firm: Report


China's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its Covid-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country's intellectual property regulator. It is the first Covid-19 vaccine patent granted by China, state-owned newspaper People's Daily reported on Sunday.

The paper cited documents published by China's National Intellectual Property Administration saying that the patent was issued on Aug. 11. ALSO READ: Malaysia detects new.....

This article is no longer available in our repository.

There could be multiple reasons for this.